VP
Insider
Versant Venture Capital VI, L.P.
10% ownerVersant Venture Capital VI, L.P. (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 2 sales), most often in LENZ Therapeutics, Inc. (LENZ). Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Sep 18 2025
Filed Sep 22 2025
Median ADV $2.6M across their filed names
Open performance→Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
LENZ
LENZ Therapeutics, Inc.
LENZ · 0 buys · 2 sells
2 filings
Recent filings
LENZSALE
LENZ Therapeutics, Inc.
View filing →
–134,904 sh across 4 lots · price not plausible
Exec Sep 18 2025
Filed Sep 22 2025 · 5:30 PM ET LENZSALE LENZ Therapeutics, Inc. View filing → –
260,713 sh across 4 lots · price not plausible
Exec Aug 15 2025
Filed Aug 19 2025 · 5:30 PM ET GLUESALE Monte Rosa Therapeutics, Inc. View filing → $1.5M
157,895 sh across 3 lots
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET